EPR1
Appearance
EPR1 | |||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Identifiers | |||||||||||||||||||||||||||||||||||||||||||||||||||
Aliases | |||||||||||||||||||||||||||||||||||||||||||||||||||
External IDs | GeneCards: [1]; OMA:- orthologs | ||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||
Wikidata | |||||||||||||||||||||||||||||||||||||||||||||||||||
|
Effector cell peptidase receptor 1, also known as EPR1, is a human gene.[1]
This locus represents an antisense transcript of the survivin locus. This record was withdrawn in collaboration with HGNC. It was defined by L26245.1, which appears to be a cloning artifact (Zaman GJ, Conway EM (July 2000). "The elusive factor Xa receptor: failure to detect transcripts that correspond to the published sequence of EPR-1". Blood. 96 (1): 145–8. doi:10.1182/blood.v96.1.145. PMID 10891443.).(This information come from https://www.ncbi.nlm.nih.gov/gene?term=L26245.1)[1]
References
Further reading
- Altieri DC (1995). "Xa receptor EPR-1". FASEB J. 9 (10): 860–5. doi:10.1096/fasebj.9.10.7615156. PMID 7615156. S2CID 8767504.
{{cite journal}}
: CS1 maint: unflagged free DOI (link) - Altieri DC (1994). "Splicing of effector cell protease receptor-1 mRNA is modulated by an unusual retained intron". Biochemistry. 33 (46): 13848–55. doi:10.1021/bi00250a039. PMID 7947793.
- Altieri DC (1994). "Molecular cloning of effector cell protease receptor-1, a novel cell surface receptor for the protease factor Xa". J. Biol. Chem. 269 (5): 3139–42. doi:10.1016/S0021-9258(17)41838-2. PMID 8106347.
- Ambrosini G, Plescia J, Chu KC, et al. (1997). "Activation-dependent exposure of the inter-EGF sequence Leu83-Leu88 in factor Xa mediates ligand binding to effector cell protease receptor-1". J. Biol. Chem. 272 (13): 8340–5. doi:10.1074/jbc.272.13.8340. PMID 9079657.
- Ambrosini G, Adida C, Sirugo G, Altieri DC (1998). "Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting". J. Biol. Chem. 273 (18): 11177–82. doi:10.1074/jbc.273.18.11177. PMID 9556606.
- Zaman GJ, Conway EM (2000). "The elusive factor Xa receptor: failure to detect transcripts that correspond to the published sequence of EPR-1". Blood. 96 (1): 145–8. doi:10.1182/blood.v96.1.145. PMID 10891443.
- Bouchard BA, Silveira JR, Tracy PB (2002). "On the role of EPR-1 or an EPR-1-like molecule in regulating factor Xa incorporation into platelet prothrombinase". Thromb. Haemost. 86 (4): 1133–5. doi:10.1055/s-0037-1616557. PMID 11686347. S2CID 7764246.
- Yamamoto T, Manome Y, Nakamura M, Tanigawa N (2003). "Downregulation of survivin expression by induction of the effector cell protease receptor-1 reduces tumor growth potential and results in an increased sensitivity to anticancer agents in human colon cancer". Eur. J. Cancer. 38 (17): 2316–24. doi:10.1016/S0959-8049(02)00247-2. PMID 12441269.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. Bibcode:2002PNAS...9916899M. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- Yao XQ, Liu FK, Li JS, et al. (2004). "Significance of effector protease receptor-1 expression and its relationship with proliferation and apoptotic index in patients with primary advanced gastric adenocarcinoma". World J. Gastroenterol. 10 (9): 1262–7. doi:10.3748/wjg.v10.i9.1262. PMC 4622763. PMID 15112339.
- Oh JH, Yang JO, Hahn Y, et al. (2006). "Transcriptome analysis of human gastric cancer". Mamm. Genome. 16 (12): 942–54. doi:10.1007/s00335-005-0075-2. PMID 16341674. S2CID 69278.